Skip to main content
Download PDF

Volume 13 Supplement 2

IX Madrid Breast Cancer Conference

  • Oral presentation
  • Published:

Epigenetics of breast cancer

Breast Cancer Research volume 13, Article number: O6 (2011) Cite this article

DNA methylation and histone modifications have important roles in normal mammary differentiation and the development of breast cancer. Epigenetically mediated silencing of tumor suppressor coding genes and microRNAs is a hallmark of human breast tumors. CpG island hypermethylation is starting to be used as a biomarker of the disease, such as BRCA1 hypermethylation as a predictor of response to PARP inhibitors. Most importantly, both DNA methylation and histone modifications are new targets for upcoming drugs.

Author information

Authors and Affiliations

  1. Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain

    M Esteller

Authors
  1. M Esteller
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Esteller, M. Epigenetics of breast cancer. Breast Cancer Res 13 (Suppl 2), O6 (2011). https://0-doi-org.brum.beds.ac.uk/10.1186/bcr3004

Download citation

  • Published:

  • DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/bcr3004

Keywords

Breast Cancer Research

ISSN: 1465-542X

Contact us